Clinical Trial

COgnitioN With VERiciGuat Evaluation in Heart Failure

Study acronym: CONVERGE-HF
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
CONVERGE-HF is a 4-center pilot phase IIb randomized control trial in ambulatory patients with chronic heart failure (≥ 6 months) and mild-to-moderate cognitive impairment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-09-13; most recent amendment 2025-07-30.
Status change: Not Yet Recruiting → Recruiting 2025-07-02
Trial Details
NCT Number NCT06601465
Lead Sponsor University of Alberta
Collaborators: Ottawa Heart Institute Research Corporation, Heart and Stroke Foundation of Canada
Conditions Heart Failure, Cognitive Impairment
Enrollment 120 participants
Start Date 2025-06-03
Primary Completion 2026-07 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-07-31